Gait and Falls in Corticobasal Syndrome

Gait and Falls in Corticobasal Syndrome

Overview

Gait and Falls in Corticobasal Syndrome

Overview

Gait disturbance and early falls are hallmark features of corticobasal syndrome (CBS), often presenting as initial symptoms and significantly impacting patient quality of life. Unlike Parkinson's disease where falls occur later, CBS is characterized by early falls and progressive gait impairment [2][3].

Clinical Features

Gait Characteristics

Gait disturbance in CBS presents with distinctive features:

• One side more affected than the other
• Reduced arm swing on the more affected side
• Dragging of the affected leg

• Overall slowing of walking speed
• Reduced stride length
• Increased time in double support phase

• Hesitation before starting to walk
• "Freezing" at initiation
• Difficulty with first step

• En-bloc turning (turning as a rigid unit)
• Multiple small steps to complete turn
• Fear of falling during turns

Freezing of Gait

Freezing of gait (FOG) is a particularly disabling feature in CBS, characterized by transient episodes where patients feel their feet are "glued to the floor" [10][11]. Unlike PD, FOG in CBS often presents earlier and may be more severe, reflecting the different underlying neuroanatomical involvement. The phenomenon is thought to arise from disruption of the automatic motor control networks involving the basal ganglia, supplementary motor area, and frontal cortical regions [10]. Freezing episodes in CBS are typically triggered by:

• Narrow spaces or doorways
• Turning movements
• Approaching destinations
• Emotional stress or dual-tasking

Postural Dyscontrol

Postural dyscontrol in CBS represents a critical determinant of fall risk and functional independence. The pathophysiology involves multiple neural systems including the basal ganglia's role in automatic postural adjustments, cerebellar contributions to balance coordination, and frontal lobe involvement in executive aspects of postural control [12]. Patients with CBS demonstrate impaired anticipatory postural adjustments (APAs) that normally prepare the body for voluntary movement, as well as deficient reactive postural responses when balance is disturbed [12].

Comparison with Other Disorders

| Feature | CBS | PSP | PD |
|---------|-----|-----|-----|
| Time to first fall | <1 year | 1-2 years | >5 years |
| Fall frequency | High | Very high | Moderate |
| Gait asymmetry | Yes | No | Mild |
| Arm swing | Reduced unilaterally | Reduced bilaterally | Reduced unilaterally |
| Freezing of gait | Common, early | Common | Common, late |

Quantitative Gait Analysis Findings

Instrumented gait analysis in CBS reveals distinctive patterns that differentiate it from other atypical parkinsonisms [3][13]. Studies using pressure-sensitive walkways and inertial measurement units have demonstrated:

These quantitative measures have been validated as sensitive markers of disease progression and therapeutic response in clinical trials [13].

Pathophysiology

Neuroanatomical Basis

Gait and balance dysfunction in CBS results from:

• Putamen and globus pallidus involvement
• Disrupted automatic movement control
• Impaired motor set shifting

• Supplementary motor area dysfunction
• Premotor [cortex](/brain-regions/cortex) involvement
• Loss of cortical control over movement

• Executive dysfunction affecting gait planning
• Reduced postural adjustments
• Impaired divided attention during walking

• Substantia nigra pars reticulata degeneration
• Pedunculopontine nucleus involvement
• Reticulospinal tract dysfunction

Mechanism of Falls

Multiple factors contribute to falls in CBS:

• Postural instability: Impaired righting reflexes
• Motor blocks: Sudden cessation of movement
• Cortical sensory loss: Impaired proprioceptive feedback
• Muscle weakness: Progressive decline in strength
• Dystonia and rigidity: Abnormal postures affecting balance

Autonomic Contributions

Autonomic dysfunction significantly contributes to gait impairment and fall risk in CBS [14]. Orthostatic hypotension (OH) is present in a substantial subset of patients and can directly cause falls through transient cerebral hypoperfusion during posture changes. Additionally, supine hypertension complicates management, as aggressive treatment of OH can worsen supine blood pressure, creating a therapeutic dilemma [14]. Autonomic testing including tilt table evaluation is recommended in CBS patients with unexplained falls.

Sleep and Gait Interactions

Rapid eye movement sleep behavior disorder (RBD) is frequently associated with CBS and other synucleinopathies, and may provide insight into underlying pathophysiology [15]. The presence of RBD correlates with more severe gait impairment and greater fall frequency, likely reflecting the extent of brainstem involvement. Additionally, sleep deprivation and nocturnal akinesia can worsen daytime gait performance, making sleep quality an important therapeutic target.

Assessment

Clinical Evaluation

• Measures time to stand, walk 3m, turn, and sit
• >13.5 seconds indicates fall risk
• CBS patients often exceed 30 seconds

• 14-item scale assessing balance
• Score <40 indicates high fall risk
• Useful for tracking progression

• 10-meter walk test
• <0.8 m/s indicates mobility issues
• Correlates with functional outcomes

Instrumented Assessment

• Force-sensitive walkways: Quantitative gait analysis
• Inertial sensors: Step/stride characteristics
• Video analysis: Qualitative gait pattern assessment

Dynamic Posturography

Dynamic posturography provides objective measures of balance dysfunction in CBS and is increasingly used in specialized movement disorder centers [16]. The Sensory Organization Test (SOT) assesses how effectively patients use visual, vestibular, and somatosensory inputs for balance. CBS patients typically show:

• Reduced composite equilibrium scores
• Impaired vestibular dependence (sway-referenced visual input)
• Deficient adaptive plasticity (repeated platform perturbations)

Fall Risk Prediction Tools

Several validated tools help predict falls in CBS:

Management

Pharmacological Approaches

• Limited benefit compared to PD
• May help some patients with bradykinesia
• Levodopa trial often attempted [17]

• For dystonia contributing to gait disturbance
• Baclofen, tizanidine

• Address mood affecting mobility
• SSRI/SNRI if indicated

• Rivastigmine has shown benefit for gait and attention in CBS [18]
• May improve dual-task gait performance
• Particularly useful in patients with cognitive impairment

Targeted Pharmacological Strategies

Emerging pharmacological approaches for gait dysfunction in CBS include:

• Botulinum toxin injections: For focal dystonia affecting gait biomechanics
• Tetrabenazine: For axial symptoms and dystonia
• Amitriptyline: Low-dose use for gait and sleep
• Methylphenidate: Investigated for executive dysfunction affecting mobility

Non-Pharmacological Interventions

• Gait training exercises
• Balance training (tandem stance, single leg stance)
• Strengthening exercises
• Transfer training

• Home safety assessment
• Assistive device training
• Energy conservation techniques

• Canes and walkers (carefully prescribed)
• Orthotics for foot drop
• Hip protectors

• Remove tripping hazards
• Install grab bars
• Improve lighting
• Use non-slip surfaces

Surgical Interventions

• Deep brain stimulation: May be considered in select cases
• Target: Globus pallidus internus or subthalamic nucleus
• Evidence: Limited compared to PD [19]
• Considerations: Must weigh cognitive decline risk against motor benefits

Emerging Rehabilitation Technologies

Novel rehabilitation approaches for gait and balance in CBS include:

Research Directions

Biomarkers

• MRI biomarkers: White matter changes correlating with gait impairment
• FDG-PET: Metabolic patterns predicting fall risk
• Wearable sensors: Continuous monitoring for fall prediction

Emerging Therapies

• Novel [tau](/proteins/tau)-targeted therapies
• Rehabilitation robotics
• Virtual reality training

Cross-References

• [Corticobasal Syndrome](/diseases/corticobasal-syndrome)
• [Eye Movement Abnormalities in CBS](/mechanisms/cbs-eye-movement-abnormalities)
• [Sleep Disorders in CBS](/mechanisms/cbs-sleep-disorders)
• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Dystonia in CBS](/mechanisms/dystonia-cbs)
• [Myoclonus in CBS](/clinical-signs/myoclonus-cbs)
• [Basal Ganglia](/brain-regions/basal-ganglia)

See Also

• [NeuroWiki Home](/home)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving Gait and Falls in Corticobasal Syndrome discovered through SciDEX knowledge graph analysis: